908 Devices (MASS) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$60.8M

Revenue (quarter)

$16.1M

Revenue growth (year over year)

+23.31%

Gross profit (trailing twelve months)

$31.7M

Gross margin

52.16%

Net income (trailing twelve months)

−$34.7M

Net income (quarter)

−$11.9M

Net income growth (year over year)

+10.61%

Net margin

−56.96%

Return on equity

−25.15%

EPS (trailing twelve months)

−$0.95

Book value per share

$3.33

P/E (trailing twelve months)

—

Price to book

3.90

Debt to assets

35.83%

Payout ratio

—

Dividend yield

—

Company profile

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

• Is 908 Devices (MASS) profitable?

  No. 908 Devices reported a net loss of $34.7M over the trailing twelve months.

• How much revenue does 908 Devices (MASS) make?

  908 Devices generated $60.8M in revenue over the trailing twelve months, up 23.31% year over year.

• How do I buy stock in 908 Devices (MASS)?

  MASS trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.